Sign in
CompletedPhase 4

Iris Vascular Area Density-Based Preoperative Pain-Risk Screening and Intervention in Second-Eye Cataract Surgery

Key facts

Who runs it
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
126 people enrolled
Started
23 Feb 2024
Ended
31 Dec 2025
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Pranoprofen eye drops
  • Prednisolone acetate eye drops
  • Sodium hyaluronate eye drops
Record updated
24 February 2026

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Aged ≥ 50 years
  • Definite diagnosis of age-related cataract
  • The first-eye cataract surgery under local anesthesia has been completed at this hospital, and the second-eye cataract surgery under local anesthesia is planned with the same surgeon within 1 year of the first-eye surgery
  • Able to cooperate with preoperative iris optical coherence tomography angiography (OCTA) examination of the operative eye
  • On the day of the second-eye surgery, preoperative iris vascular area density (VAD) ≥ 0.2167 in the operative eye

Who cannot take part

  • Severe complications during or after the first-eye surgery (e.g., posterior capsule rupture, zonular dialysis, dislocation of the lens nucleus into the vitreous cavity, postoperative endophthalmitis, or glaucoma)
  • Long-term use of opioids, other systemic analgesics, or sedative-hypnotic drugs
  • Use of topical corticosteroid eye drops in the second eye within 1 month prior to the planned surgery
  • Participation in any other clinical trial involving ophthalmic or systemic drugs within the past 6 months
  • History of ocular trauma, ocular surgery (excluding the first-eye cataract surgery already performed), uveitis, chorioretinal disease, glaucoma
  • Presence of significant corneal disease, marked iris abnormalities, or any active ocular surface disease, including recent conjunctivitis, keratitis, or severe dry eye
  • History of chronic pain syndromes or neuropathic pain
  • Known autoimmune disease or ongoing immunosuppressive therapy
  • Severe psychiatric disorders or cognitive impairment interfering with pain assessment
  • Long-term use of α-adrenergic blockers or other medications associated with intraoperative floppy iris syndrome (IFIS)
  • Known allergy or contraindication to topical nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., pranoprofen) or topical corticosteroids (e.g., prednisolone acetate) used in this study

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This clinical trial aims to evaluate the effectiveness of pranoprofen or prednisolone acetate eye drops for pain management in patients undergoing second-eye surgery for age-related cataracts. Researchers will compare pranoprofen or prednisolone acetate eye drops with sodium hyaluronate eye drops to determine whether pranoprofen or prednisolone acetate eye drops can relieve intraoperative pain during second-eye cataract surgery.

Read full original descriptionShow less

Participants will:

1. Receive one drop in the operative eye at 2 hours, 1.5 hours, 1 hour, and 30 minutes before cataract surgery (pranoprofen, prednisolone acetate, or sodium hyaluronate) 2. Undergo cataract surgery and routine postoperative follow-up 3. Within 1 hour after surgery, provide a pain visual analog scale (VAS) score under the guidance of the investigator

The 3 groups in the trial

  • Pranoprofen ophthalmic solution groupTreatment being tested

    Treatment: Pranoprofen eye drops

  • Prednisolone acetate ophthalmic suspension groupTreatment being tested

    Treatment: Prednisolone acetate eye drops

  • Sodium hyaluronate ophthalmic solution groupPlacebo, for comparison

    Treatment: Sodium hyaluronate eye drops

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Preoperative Pain-Risk Screening and Intervention for Intraoperative Pain in Second-Eye Cataract Surgery Based on Iris Vascular Area Density
Record updated
24 February 2026